Selective bowel decontamination versus inactive control · people undergoing liver transplantation
It is very uncertain whether intervention changes selective bowel decontamination versus inactive control compared with control (very low certainty).
2 findings from 1 review
Selective bowel decontamination versus prebiotics with probiotics · people undergoing liver transplantation
2 findings from 1 review
Selective bowel decontamination versus prebiotics · people undergoing liver transplantation
2 findings from 1 review
All‐cause mortality · adults with cirrhosis and gastroesophageal varices
Carvedilol showed no clear difference in mortality compared with traditional, non‐selective beta‐blockers (low certainty).
1 finding from 1 review
Upper gastrointestinal bleeding · adults with cirrhosis and gastroesophageal varices
It is very uncertain whether carvedilol changes upper gastrointestinal bleeding compared with traditional, non‐selective beta‐blockers (very low certainty).
1 finding from 1 review
Serious adverse events · adults with cirrhosis and gastroesophageal varices
Carvedilol showed no clear difference in serious adverse events compared with traditional, non‐selective beta‐blockers (low certainty).
1 finding from 1 review
Non‐serious adverse events · adults with cirrhosis and gastroesophageal varices
It is very uncertain whether carvedilol changes non‐serious adverse events compared with traditional, non‐selective beta‐blockers (very low certainty).
1 finding from 1 review
Hepatic venous pressure gradient at end of treatment (mmHg) · adults with cirrhosis and gastroesophageal varices
1 finding from 1 review
Reduction in hepatic venous pressure gradient (%) · adults with cirrhosis and gastroesophageal varices
1 finding from 1 review
Haemodynamic treatment failure · adults with cirrhosis and gastroesophageal varices
It is very uncertain whether carvedilol changes haemodynamic treatment failure compared with traditional, non‐selective beta‐blockers (very low certainty).
1 finding from 1 review